HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Marshall L. Jacobs Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacobs, M. L. Search for Related Content PubMed PubMed Citation Articles by Jacobs, M. L. Related Collections Great vessels Molecular biology Related Article

---

Original Articles: Pediatric Cardiac

Invited Commentary

Department of Cardiothoracic Surgery, Drexel University College of Medicine, Philadelphia, PA 19102

(Email: marshall.jacobs@comcast.net).

The first 20% of the full text of this article appears below.

Nearly half a century has passed since Donald Ross' first report of homograft replacement of the aortic valve. Four years after that, he described the use of an aortic valved homograft as an extracardiac conduit to restore right ventricle-to-pulmonary artery continuity in the setting of pulmonary atresia. Currently, cryopreserved cadaveric aortic and pulmonary valved homografts are widely used in the reconstruction of congenital cardiac anomalies in infants, children, and adults.

Pulmonary valved homografts are used nearly exclusively to reconstruct the right ventricular outflow tract in the setting of pulmonary autograft replacement of the aortic valve. Homograft vascular patches are used to reconstruct aortic and pulmonary artery architecture in settings such as the Norwood procedures for hypoplastic left heart syndrome and related lesions. The use of cryopreserved homograft arterial tissue has been advocated to replace mycotic aneurysms and for other arterial . . . [Full Text of this Article]

Related Article

Expression of A and B Blood Group Antigens on Cryopreserved Homografts

Brian Feingold, Peter D. Wearden, Victor O. Morell, Daniel Galvis, and Csaba Galambos
Ann. Thorac. Surg. 2009 87: 211-214. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				W. F. Northrup III and S. Goldstein Potential Benefits of Antigen Reduction in Heart Valve Allografts Ann. Thorac. Surg., July 1, 2010; 90(1): 357 - 357. [Full Text] [PDF]

				B. Feingold, P. D. Wearden, V. O. Morell, D. Galvis, and C. Galambos Reply Ann. Thorac. Surg., July 1, 2010; 90(1): 357 - 358. [Full Text] [PDF]